secwatch.observer — SEC 8-K summary
======================================

Issuer:     MCKESSON CORP (MCK)
CIK:        0000927653
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0000927653-24-000121
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

McKesson Q2 FY2025 revenue $93.7B (+21%), adj. EPS $7.07 (+13%), raises FY25 adj. EPS guidance
--------------------------------------------------------------------------------

- Revenue $93.7B, +21% YoY; GAAP diluted EPS $1.87 (down 62% vs $4.92); adjusted EPS $7.07 (+13%).
- Raises FY2025 adjusted EPS guidance to $32.40-$33.00 from $31.75-$32.55, implying 18-20% growth.
- Announced agreement to acquire controlling interest in Florida Cancer Specialists & Research Institute's Core Ventures.
- Announced agreement to sell Canada-based Rexall and Well.ca retail businesses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/927653/000092765324000121/0000927653-24-000121-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/927653/000092765324000121/mck-20241106.htm
  HTML page:      https://secwatch.observer/filing/0000927653-24-000121

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer